Bragg Financial Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-7,812
| Closed | -$392K | – | 253 |
|
|
2018
Q3 | $392K | Hold |
7,812
| – | – | 0.05% | 209 |
|
|
2018
Q2 | $394K | Hold |
7,812
| – | – | 0.06% | 205 |
|
|
2018
Q1 | $382K | Hold |
7,812
| – | – | 0.06% | 215 |
|
|
2017
Q4 | $346K | Buy |
7,812
+36
| +0.5% | +$1.59K | 0.05% | 226 |
|
|
2017
Q3 | $395K | Sell |
7,776
-54
| -0.7% | -$2.74K | 0.06% | 212 |
|
|
2017
Q2 | $422K | Hold |
7,830
| – | – | 0.07% | 211 |
|
|
2017
Q1 | $413K | Hold |
7,830
| – | – | 0.07% | 216 |
|
|
2016
Q4 | $377K | Hold |
7,830
| – | – | 0.06% | 220 |
|
|
2016
Q3 | $422K | Buy |
7,830
+214
| +3% | +$11.5K | 0.08% | 212 |
|
|
2016
Q2 | $413K | Hold |
7,616
| – | – | 0.07% | 211 |
|
|
2016
Q1 | $386K | Hold |
7,616
| – | – | 0.07% | 210 |
|
|
2015
Q4 | $384K | Sell |
7,616
-172
| -2% | -$8.67K | 0.08% | 199 |
|
|
2015
Q3 | $374K | Sell |
7,788
-318
| -4% | -$15.3K | 0.09% | 189 |
|
|
2015
Q2 | $422K | Buy |
8,106
+278
| +4% | +$14.5K | 0.1% | 191 |
|
|
2015
Q1 | $452K | Buy |
7,828
+172
| +2% | +$9.93K | 0.1% | 187 |
|
|
2014
Q4 | $409K | Sell |
7,656
-364
| -5% | -$19.4K | 0.1% | 185 |
|
|
2014
Q3 | $461K | Hold |
8,020
| – | – | 0.12% | 179 |
|
|
2014
Q2 | $536K | Hold |
8,020
| – | – | 0.13% | 174 |
|
|
2014
Q1 | $536K | Hold |
8,020
| – | – | 0.13% | 174 |
|
|
2013
Q4 | $535K | Hold |
8,020
| – | – | 0.13% | 175 |
|
|
2013
Q3 | $503K | Hold |
8,020
| – | – | 0.13% | 173 |
|
|
2013
Q2 | $501K | Buy |
+8,020
| New | +$501K | 0.14% | 166 |
|